Immunosuppressive drugs are widely used in the treatment of organ transplantation, autoimmune diseases, and various chronic inflammatory conditions. While suppressing the immune system, these drugs can also weaken the skin's defense mechanisms, creating a basis for various dermatological problems. In 2026, interest in medical aesthetic procedures among patients on immunosuppressive therapy has increased, making the development of specialized protocols essential.
Effects of Immunosuppressive Drugs on the Skin
Long-term use of corticosteroids leads to marked changes in the skin. Skin thinning, easy bruising, striae formation, acneiform eruptions, and delayed wound healing are the most commonly encountered presentations. Additionally, Cushing's syndrome developing as a result of steroid use can cause significant changes in facial contour and body fat distribution.
Patients using cyclosporine may experience hirsutism, gingival hyperplasia, and seborrheic changes. Methotrexate can cause mucosal ulcerations, photosensitivity, and hair loss. Patients on mycophenolate mofetil have an increased susceptibility to viral skin infections.
In organ transplant recipients, skin cancer risk rises markedly due to immunosuppressive therapy. The risk of squamous cell carcinoma may increase 65 to 250 times compared to the general population. Regular dermatological follow-up is therefore of vital importance for this patient group.
Safety in Medical Aesthetic Procedures
Medical aesthetic procedures in patients on immunosuppressive drugs require special attention. The most important risk factor is infection. A suppressed immune system can open the door to serious infections even in procedures that are ordinarily uneventful.
Maximum attention to sterility conditions must be maintained when performing injection procedures (fillers, botulinum toxin). Pre- and post-procedure prophylactic antibiotic use should be considered. The risk of biofilm formation with hyaluronic acid fillers may be higher in this patient group.
Healing time may be prolonged in treatments using laser and energy-based devices. Ablative laser procedures are generally not recommended for this patient group. Non-ablative approaches offer a safer alternative; however, treatment parameters should still be kept conservative.
Pre-Treatment Evaluation
A comprehensive assessment should be performed before any procedure in every patient on immunosuppressive therapy. Current blood counts, particularly white blood cell count and lymphocyte subsets, should be checked. If the level of immunosuppression falls below a certain threshold, the procedure should be postponed.
All medications the patient is taking should be reviewed in detail and potential drug interactions evaluated. The treatment decision must always be made in coordination with the patient's immunology or rheumatology specialist.
Skin Care Recommendations
A daily skin care protocol is of great importance for patients on immunosuppressive drugs. Use of broad-spectrum sunscreen is a critical step in reducing skin cancer risk. Moisturizing products that strengthen the skin barrier should be used regularly, and any abnormal change noticed in the skin should prompt immediate dermatological evaluation.
Conclusion
Patients on immunosuppressive drugs can safely benefit from medical aesthetic treatments when the correct protocols are followed. At Virtuana Clinic, we manage the treatment process for this special patient group in coordination with the relevant specialist physicians to ensure the highest safety standards.